WSGR Healthcare Investment Forum
November 6-9, 2018
Palo Alto, CA
Wilson Sonsini Goodrich & Rosati's Healthcare Investment Forum presents an opportunity for life sciences venture investment firms to connect with promising start-ups to discuss potential funding. WSGR is the premier provider of legal services to technology, life sciences, and growth enterprises worldwide.
Registration for this event is closed for submissions. Any emailed materials will not be accepted for consideration. Only confirmed investors and their selected companies will be able to attend.
How it Works
Entrepreneurs and early-stage life sciences companies may apply to privately pitch their ideas for investment. Participating investors will individually review company submissions and select who they would like to meet, each for 40 minutes.
Selected companies must have flexible availability for meetings in Palo Alto, California between 8:00 a.m. – 5:00 p.m. on program dates. Actual meeting date(s) will be determined based on the date that each investor will be meeting with companies. Companies will be notified whether or not they have been selected for one or more investor meetings by October 10. If selected, your meeting date(s) and time(s) will be provided at that point.
5AM Ventures, AbbVie Ventures, Accelerator Life Science Partners, Alexandria Ventures, Apple Tree Partners, ARCH Venture Partners, Artis Ventures, Astellas Venture Management, BioGeneration Ventures (BGV), Boehringer Ingelheim, Brace Pharma Capital, BridgeBio, Civilization Ventures, Danaher, DigiTx Partners, Embark Ventures, Frazier Healthcare Partners, Genoa Ventures, GE Ventures, Global Health Investment Fund, Gurnet Point Capital, Hatteras Venture Partners, Illumina Ventures, LaunchPad Digital Health, Lightspeed Ventures, Longevity Fund, Medeon Bio, Menlo Ventures, MPM Capital, NanoDimension, New Enterprise Associates (NEA), Novo Ventures, OrbiMed, Pappas Capital, Pfizer, Inc., Pivotal bioVenture Partners, Quark Venture, RA Capital, River Cities Capital Funds, Satter Investment Management, Siemens Healthineers, Sofinnova Ventures, SR One, Taiho Ventures, Takeda Ventures, Thiel Capital, venBio, Versant Ventures, Vida Ventures, and Vivo Capital.
Submission Deadline: Sunday, August 12, 2018
- Submit the registration form below
- Email executive summary* and non-confidential presentation deck (include company name in the email subject line)
*Executive summaries should be formatted as a 1-2 page PDF document, and include: (1) a summary of your technology and the business opportunity; and (2) a list of your executive management team and their experience.
For more information, please contact us at (650) 565-7206.